What is SAM-e and what does it do?
SAM-e is an important methyl donor in cells. It is involved in DNA, protein, and phospholipid methylation; neurotransmitter biology; the homocysteine-methionine cycle, and glutathione synthesis. For this reason, it has been researched in the fields of psychiatry, joint health, liver, and redox biology.
Human data in depressive symptoms
In a systematic review and meta-analysis published in 2024 including 23 randomized trials, SAM-e monotherapy demonstrated a moderate positive effect compared to placebo in reducing depressive symptoms. Results regarding the addition of SAM-e to antidepressants or its comparison with active antidepressants were more variable. Another meta-analysis published in the same year also noted that SAM-e could show symptom improvement similar to antidepressants in some studies, but that cautious interpretation is required due to the number of studies and dose heterogeneity.
These results make SAM-e an intriguing supportive option; psychiatric evaluation and evidence-based treatment must not be delayed in cases of major depression diagnosis, suicide risk, or severe functional impairment.
Osteoarthritis and pain
SAM-e has also been studied in osteoarthritis pain and function. In a meta-analysis of randomized trials, improvement in functional limitation compared to placebo and clinical outcomes similar to NSAIDs were reported; the database is older and variations exist among studies. Therefore, in contemporary osteoarthritis management, evaluating it alongside exercise, weight management, appropriate analgesia, and other standard options is more meaningful.
Liver and glutathione biology
Due to SAM-e’s relationship with the methionine cycle and glutathione synthesis, research has been conducted in cholestasis and various liver diseases. Because clinical benefit varies by disease type and study, rather than making a plan based on a supplement alone in liver disease, the diagnosis and standard hepatology approach should serve as the foundation.
Are oral, IM, and IV uses the same?
No. The SAM-e literature includes oral and some parenteral administrations; route of administration, bioavailability, and preparation characteristics differ. A result from an oral study cannot be directly transferred to an IV formulation. If IV administration is being considered, the product’s suitability for injection, pharmaceutical form, stability, sterility, and clinical use data must be verified separately.
Why are B12, folate, and homocysteine important?
Because SAM-e is part of the methylation cycle, folate, B12, and B6 status along with homocysteine metabolism may carry importance in a clinical context. Particularly in long-term use or with the risk of nutritional deficiency, evaluating this axis together provides a more holistic approach.
Safety and drug interactions
SAM-e can affect serotonergic pathways. Concomitant use with SSRIs, SNRIs, MAOIs, tricyclic antidepressants, or other serotonergic medications requires physician supervision; caution should be exercised regarding serotonin toxicity. Particular caution is needed in individuals with bipolar disorder, as it can trigger mania or hypomania. Nausea, gastrointestinal complaints, headache, restlessness, and sleep changes may be observed.
Our approach at our Bodrum clinic
We do not approach SAM-e as a standardized application in the form of an “energy IV drip”; rather, we evaluate it in conjunction with mood, pain, liver-methylation biology, B12-folate status, homocysteine, current medications, and psychiatric history. In suitable patients, the form and route of administration to be used are chosen based on the clinical objective; serotonergic medications and a history of bipolar disorder are specifically investigated.
Frequently asked questions
Can SAM-e help with depressive symptoms?
In a 2024 meta-analysis of randomized trials, positive results were reported compared to placebo. Individual response and the most appropriate treatment combination vary depending on diagnosis, medications used, and disease severity.
Can SAM-e be used for joint pain?
In osteoarthritis studies, it has been investigated in terms of pain and function, and some positive results have been reported. A current plan should be established together with exercise, weight, biomechanical factors, and other treatment options.
Related content
You can explore the guides on Pain treatment, Knee pain and osteoarthritis, Vitamin B12, Folate and methylfolate, and IV and infusion therapies.
References
2024 depression systematic reviews/meta-analyses; meta-analysis of randomized trials in osteoarthritis; NCCIH SAM-e fact sheet.
Written and medically reviewed by: Dr. Kerem Çağlayan
Last medical review: September 10, 2026
